Top Markets
#1 Tensor Tensor +34.42%
#2 Blur Blur +19.40%
#3 Ontology Gas Ontology Gas +17.50%
#4 XPIN Network XPIN Network +15.53%
#5 Dymension Dymension +14.91%
#6 Irys Irys +13.80%
#7 Corn Corn +11.17%
#8 Naoris Protocol Naoris Protocol +10.00%
#9 Tradoor Tradoor +9.51%
#10 Enjin Coin Enjin Coin +9.26%
Coin of the day
Tensor Tensor
Settings
Language
ENGLISH
Currency
USD
Theme
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Rank in Stocks #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Share Price
$0.51099792
Market Cap
$13.22M
Change (1 day)
-0.54%
Change (1 year)
99.27%
Country
SE
Trade Clinical Laserthermia Systems AB (publ) (CLS-B)

Category

Healthcare
Revenue for Clinical Laserthermia Systems AB (publ) (CLS-B)
Revenue in Dec 2025 TTM: $1.90M
According to Clinical Laserthermia Systems AB (publ) latest financial reports the company's current revenue (TTM) is $1.90M. In 2023 the company made a revenue of $820.05K an increase over the revenue in the year 2022 that was $601.11K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Clinical Laserthermia Systems AB (publ) from 2008 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.90M 11.28%
2024 $1.70M 107.67%
2023 $820.05K 36.42%
2022 $601.11K 142.32%
2021 $248.06K 53.91%
2020 $161.18K 5.51%
2019 $152.76K -24.52%
2018 $202.38K 169.31%
2017 $75.15K -81.23%
2016 $400.32K 0.00%
2015 0.00 0.00%
2014 0.00 -100.00%
2013 $1.86K -90.15%
2012 $18.93K -62.76%
2011 $50.82K -2.70%
2010 $52.23K 86.37%
2009 $28.03K 46.45%
2008 $19.14K 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $44.33B 2,338,873.19%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.12B 1,325,149.29%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 $35.49B 1,872,627.28%
IE
Medtronic Medtronic
Medtronic
MDT.US
 $35.48B 1,872,218.28%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $20.08B 1,059,160.22%
US